Home › Juvenile Myelomonocytic Leukemia › Michigan › Ann Arbor
Juvenile Myelomonocytic Leukemia clinical trials in Ann Arbor, MI
3 studies for Juvenile Myelomonocytic Leukemia are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RecruitingPhase 1/2
- C.S. Mott Children's Hospital, Ann Arbor
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RecruitingPhase 1
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- C S Mott Children's Hospital, Ann Arbor
Juvenile Myelomonocytic Leukemia trials in other cities
- Philadelphia, PA4 studies
- Minneapolis, MN4 studies
- Boston, MA3 studies
- Chicago, IL3 studies
- Washington, DC3 studies
- Memphis, TN3 studies
- New York City, NY3 studies
- Indianapolis, IN3 studies
- Atlanta, GA3 studies
- Cincinnati, OH3 studies
- San Francisco, CA3 studies
- Seattle, WA3 studies
Other studies in Ann Arbor
- Breast Cancer27 studies
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Stroke12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.